GamaMabs debuts with EUR 3.1M series A round

Newco GamaMabs Pharma S.A. (Toulouse, France) debuted with a EUR 3.1 million ($4.2 million) series A round led by Bpifrance through its InnoBio fund, with participation from IRDINov and iXO Private Eq...